More Videos
- Credit Crisis Runs Through Charles River Labs
- FDA Commissioner: Betting Starts On Who Obama Will Pick
- Big Pharma "Healthier" For Obama With Campaign Money
- Genzyme And Osiris "Elect" To Get Together On Stem Cells
- Merck Goes Back To School
- Diabetes Drug Dollars: Money Well Spent?
- Dendreon's "Short" Shrift
- Pfizer & Lilly Prove Me Wrong
- Merck Shows "Sensitivity" Amid Massive Cuts
- Roche Still Chasing Genentech
- 9 Solid Stocks for Rebuilding Your Portfolio
- Yahoo!'s Yang: The 'Height of Hubris'
- Lightning Round: Intel, ABB, Goldman Sachs and More
- Lightning Round OT: Quanta Services, Jacobs Engineering and More
- Sell Block: The Problem With Analysts
- Executive Decision: Tupperware CEO Rick Goings
- Buffett's Buying, But Should You?
- Your First Move For Friday November 7th
- Web Extra: Battle The Bear
- British Airways Lifts Revenue Target, Shares Jump
- Sprint Nextel Posts Loss as Customers Flee
- What the Pros Say: 300,000 Jobs Lost in October
- Obama Should Show International Leadership: El-Erian
- US Economy 'Has Fallen off a Cliff': El-Erian
- Euro Shares Rise as Commodities Rebound
- PC Maker Lenovo's Quarterly Earnings Plunge
- Microsoft CEO Pours Cold Water on Yahoo Interest
- DBS Profit Dips 38%; Bank Warns About Outlook
Text Size 
 |
CNBC.com |
But, when the CRP, on its web site, www.opensecrets.org, breaks it down to just the drug manufacturers (i.e. Amgen [AMGN
Loading...
()
] , Pfizer [PFE
Loading...
()
] , GlaxoSmithKline [GSK
Loading...
()
] , etc.), Obama beats Clinton by 3-grand. Sen. John McCain remains in 15th place on the list of presidential/congressional candidate recipients of money from pharma/health products. But since the last report, he's moved up two notches to 11th position on the recipient list from drugmakers. Gov. Mike Huckabee doesn't appear in the top-20 in either category.
You can check out the pharma/health products recipient list here and the drug manufacturers' list here.
According to the CRP, the pharma/health products sector is now splitting its donations evenly between Democrats and Republicans. In the last presidential election cycle it favored the GOP by a two-to-one margin. While the drugmakers, so far, have given 47 percent of their campaign cash to Dems and 53 percent to Republicans. In 2004, it was 30-70, respectively.
Related PM Posts |
Biotech behemoth Amgen is still the biggest giver (nearly three-quarters of a million dollars), followed by Pfizer, Glaxo, Johnson and Johnson [JNJ
Loading...
()
] and Roche (which owns a majority stake in another biotech giant, Genentech [DNA
Loading...
()
] ). Most, but not all, of the individual drug companies are giving more of their money to Republicans (Pfizer, whose CEO has twice given the maximum personal contribution to Clinton, is one of the exceptions).
And, interestingly, generic drugmaker Mylan Labs [MYL
Loading...
()
] , favors Democrats (67 percent) over Republicans (33 percent). Perhaps the conventional political wisdom there is that the Dems might work harder to make it easier to get cheaper generic drugs to market. And sleeping pill manufacturer Sepracor [SEPR
Loading...
()
] (it makes Lunesta--the one with the opaque butterfly in the commercial) has thrown 83 percent of its cash at Democrats.
Analysts say the industry is simply trying to make sure it has a place at the table if/when healthcare reform is discussed. Others say it supports their thesis that the Democrats' bark might be worse than their bite--that yes, there's a lot of populist campaign rhetoric about "taking on the drug companies," but that the financial support may be a better "tell" of their true position when push comes to shove. Our chief political correspondent, John Harwood, says the flow of pharma funds to the presidential candidates tells you more about the way the election is tilting than any voter poll.
related content |
Questions? Comments?
Del.icio.us
Digg It
Data is a real-time snapshot *Data is delayed at least 15 minutes